News

The country halted the Sinovac investigational vaccine due to what was being reported as a serious adverse event.

Alzheimer’s disease, dementia, and genetic variations in areas key to viral infection are risk factors for severe COVID-19 a new study suggests.

Bamlanivimab should be administered as soon as possible after a positive test, and within 10 days of developing symptoms, Eli Lilly said.

When administered every two months, cabotegravir is 89% more effective than daily pills in preventing HIV acquisition in women.

The new research letter also highlights a concerning rate of infection among Latino patients.

The company is still awaiting its threshold for total COVID-19 infections in its 44,000-patient assessment. Nonetheless, they believe they have made history.

A new survey shows just 2% of children with rheumatic disease reported COVID-19 positive test results or symptoms through early May.

New findings show subsequent drops in incidence, hospitalizations, and mortalities once the state set stay-at-home orders, mask mandates, and contact tracing.

The final report of remdesivir trial supports its approved treatment for COVID-19 after preliminary findings enabled emergency use authorization.

A similar shutdown seems inevitable, but there may be an alternative.

The test simultaneously recognizes the S1 and S2 subunits of the virus' spike protein in one sample, providing better sensitivity.

Neurological symptoms of COVID-19 ranging from dizziness to microclots could be the result of destabilization of the blood-brain barrier caused by virus spike proteins circulating in the blood.

The country moves into a difficult phase of the pandemic as fall slides into winter with no national mandates and no vaccine.

In a survey, a panel of experts sees the American response as problematic and weighs in on universal masking.

Phase 2 trial demonstrates novel investigational antifungal Fosmanogepix is tolerated and efficacious in patients with renal Insufficiency.

Investigators found these populations are younger and are living at or below poverty were at lower adherence to ART.

Disagreement among health officials, politicians, and the media leads to inconsistent levels of compliance with guidelines.

LY-CoV555 was derived from a patient with COVID-19 and developed by Eli Lilly.

The company recently announced it was in a phase 1 trial.

Data suggest New York City COVID-19 cases could have been reduced by 80% in two months if social distancing was implemented a week earlier than it was.

We asked a simple question to our IDWeek experts: has COVID-19 taken attention away from any greater infectious disease issues?

A Medicare program provided more point-of-care testing devices this summer. Yet, even hot-spot facilities are far more likely to receive results in ≥3 days than 1.

The investigational antibody used to treat President Trump shows it reduced viral load and medical visits.

Vaccination for VZV and HPV requires special consideration in immunocompromised patients. They are at risk for more severe viral illnesses if not immune, but they may also have decreased response to, and increased adverse effects from, vaccines.

A balance between antimicrobial stewardship and the search for multidrug-resistant organisms.

As the threat of infection with multidrug-resistant gram-negative organisms persists, new antimicrobials are a welcome addition to the armamentarium of infectious diseases clinicians.